Lifestyle Factors that Improve Metabolic Syndrome Components
Recruitment
Design
Blinding used (if applicable)
Intervention (if applicable)
Statistical Analysis
Timing of Measurements
N/A
Dependent Variables
- Variable 1: brief description (how measured?)
- Variable 2: brief description (how measured?)
- etc
Independent Variables
Control Variables
N/A
Initial N: (e.g., 731 (298 males, 433 females))
Attrition (final N):
Age:
Ethnicity:
Other relevant demographics:
Anthropometrics (e.g., were groups same or different on important measures)
Location:
Identified 3 potential etiologic categories: obesity, insulin resistance and constellation of independent risk factors
Management of Underlying Risk Factors
-the risk factors that promote the development of the MS are overweight/obesity, physical inactivity, and an atherogenic diet.
-first line of therapy should be lifestyle modification (weight loss and physical activity)
Management of overweight and obesity
-Reduce caloric intake and increased physical activity:
-Crash diets/extreme diets don't work. More effective and healthful for long-term weight loss
and 500 to 1000 calorie/day restrictions
-Realistic goal is to reduce body weight by 7-10% over 6-12 months
-Long-term maintenance is best achieved when regular exercise is included in the weight
loss regimen
-Emphasis should be given to eating habits, social support, stress management and regular
exercise.
Management of physical inactivity
-Daily minimum of 30 minutes of moderate-intensity physical activity, increasing the level
(1 hour/day) appears to be more beneficial, especially for weight control
-To help initiate activity, suggestions to start with 10-15 bouts of activity
Dietary Modification
-Diet composition consistent with general dietary recommendations: low intake of SF, trans-
fat and cholesterol; reduced consumption of simple sugars; increased intake of fruits and
vegetables, and whole grains.
-Further research needed to see if MS pts will benefit from a shift to more unsaturated fatty
acids and less carbohydrates
Variables |
Treatment Group Measures and confidence intervals |
Control group Measures and confidence intervals |
Statistical Significance of Group Difference |
Dep var 1 |
Mean, CI. e.g., 4.5±2.2 |
Mean, CI. e.g., 1.5±2.0 |
Stat signif difference between groups e.g., p=.002 |
Dep var 2 |
|
|
|
etc |
|
|
|
Other Findings
Lifestyle modification leading to weight reduction and increased physical activity represents first-line clinical therapy. Smoking cessation is paramount. A realistic goal for weight loss is to reduce body weight by 7-10% over 6 months to 1 year. Weight reduction should be combined with a daily minimum of 30 minutes of moderate-intensity activity. Nutritional therapy calls for a low intake of SF, trans-fatty acids and cholesterol; reduced consumption of simple sugars; and increased fruits and vegetables and whole grains. Extremes in intakes of either carbohydrate or fats should be avoided.
Many limitations due to the nature of the paper.
Quality Criteria Checklist: Review Articles
|
|||
Relevance Questions | |||
1. | Will the answer if true, have a direct bearing on the health of patients? | Yes | |
2. | Is the outcome or topic something that patients/clients/population groups would care about? | Yes | |
3. | Is the problem addressed in the review one that is relevant to dietetics practice? | Yes | |
4. | Will the information, if true, require a change in practice? | Yes | |
Validity Questions | |||
1. | Was the question for the review clearly focused and appropriate? | Yes | |
2. | Was the search strategy used to locate relevant studies comprehensive? Were the databases searched and the search termsused described? | No | |
3. | Were explicit methods used to select studies to include in the review? Were inclusion/exclusion criteria specified andappropriate? Wereselectionmethods unbiased? | No | |
4. | Was there an appraisal of the quality and validity of studies included in the review? Were appraisal methodsspecified,appropriate, andreproducible? | No | |
5. | Were specific treatments/interventions/exposures described? Were treatments similar enough to be combined? | No | |
6. | Was the outcome of interest clearly indicated? Were other potential harms and benefits considered? | No | |
7. | Were processes for data abstraction, synthesis, and analysis described? Were they applied consistently acrossstudies and groups? Was thereappropriate use of qualitative and/or quantitative synthesis? Was variation in findings among studies analyzed? Were heterogeneity issued considered? If data from studies were aggregated for meta-analysis, was the procedure described? | No | |
8. | Are the results clearly presented in narrative and/or quantitative terms? If summary statistics are used, are levels ofsignificance and/or confidence intervals included? | Yes | |
9. | Are conclusions supported by results with biases and limitations taken into consideration? Are limitations ofthe review identified anddiscussed? | No | |
10. | Was bias due to the review's funding or sponsorship unlikely? | Yes | |